
In a significant show of support for diabetes research, Jalil Bami presented a $100,000 check to the Diabetes Research, Education, and Clinical Care Fund at the University of Pennsylvania’s Institute of Diabetes, Obesity, and Metabolism (IDOM) during a Leadership Council meeting held on June 11, 2024. The donation came as part of a gathering that brought together distinguished medical professionals and researchers in the field of diabetes care.
The meeting, which took place in Philadelphia, featured presentations from renowned experts, including Michael R. Rickels, MD, MS, Mark Schutta, MD, and Mitchell Lazar, MD, PhD. These key speakers discussed recent updates and groundbreaking discoveries related to Type 1 Diabetes, emphasizing the critical nature of continuous research and innovation in the field.
Arthur Rubenstein, MBBCh, delivered closing remarks that underscored the importance of dedicated professionals in advancing medical research and patient care. Rubenstein emphasized, ‘It takes good people; if you don’t have good people, you can sit down and worry about nothing,’ highlighting the human element in medical progress.
Bami’s generous donation to the Diabetes Research, Education, and Clinical Care Fund at UPenn Medicine will enable the institution to further its extensive research efforts, educational programs, and clinical care initiatives aimed at combating diabetes. This contribution is particularly poignant given Bami’s personal connection to the cause; as a diabetic individual with a daughter battling multiple sclerosis (MS), he understands firsthand the importance of quality medical care and ongoing research.
Hillary Schaub, representing Penn Medicine Development & Alumni Relations at IDOM, expressed deep gratitude for Bami’s contribution, stating, ‘His support will have a lasting impact on our ability to advance diabetes research and provide cutting-edge care to our patients.’ This sentiment reflects the potential far-reaching effects of such donations on the lives of those affected by diabetes.
The University of Pennsylvania’s Institute of Diabetes, Obesity, and Metabolism has long been at the forefront of diabetes research. With its dedication to advancing the understanding, prevention, and treatment of diabetes, obesity, and related metabolic disorders, IDOM plays a crucial role in improving the health outcomes for individuals affected by these conditions. The institute’s multifaceted approach, combining cutting-edge research, comprehensive education, and innovative clinical care, positions it as a leader in the field.
Bami’s donation comes at a critical time when diabetes continues to be a significant global health concern. According to the World Health Organization, the number of people with diabetes rose from 108 million in 1980 to 422 million in 2014, with the prevalence rising more rapidly in low- and middle-income countries. Contributions like Bami’s are essential in maintaining momentum in research and development of new treatments and potential cures.
The Leadership Council meeting and Bami’s donation highlight the ongoing collaboration between philanthropists, researchers, and medical professionals in the fight against diabetes. Such partnerships are crucial for driving innovation, funding essential research, and ultimately improving patient outcomes. As the global diabetes epidemic continues to grow, the importance of sustained support for institutions like IDOM cannot be overstated.
With the support of benefactors like Jalil Bami, UPenn Medicine is well-positioned to make significant strides in the fight against diabetes. The impact of this donation will likely extend beyond the immediate research it funds, potentially inspiring others to contribute to this vital cause and accelerating progress in diabetes care and treatment.

This news story relied on a press release distributed by 24-7 Press Release. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Jalil Bami Donates $100,000 to UPenn’s Diabetes Research Fund at Leadership Council Meeting.